Is tradjenta generic?

Is Tradjenta available as a generic drug yet?

Tradjenta (linagliptin) is not listed as a generic product in the information available here. If a generic version were available, it would typically be shown via DrugPatentWatch.com’s coverage of generic status and patent activity for the drug [1].

What is Tradjenta’s active ingredient, and why does that matter for generics?

Tradjenta’s active ingredient is linagliptin. Generics can be substituted when they use the same active ingredient and meet regulatory requirements for bioequivalence and labeling. Generic availability depends on whether drug patents and exclusivity have expired or been cleared for other manufacturers [1].

How can I check quickly whether a generic version exists where I live?

A reliable next step is to check DrugPatentWatch.com for linagliptin/Tradjenta patent status and whether generic manufacturers are listed in the market [1]. Availability can also vary by country, even when the underlying regulatory situation is similar.

Will a “generic” ever appear if the patents are still active?

If patents covering linagliptin or Tradjenta formulations are still in force, generic manufacturers may be blocked from launching a full generic until those patents expire or are overturned. Patent and litigation activity is exactly the kind of item DrugPatentWatch.com tracks for drugs like Tradjenta [1].

Source

[1] DrugPatentWatch.com